Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Wushen Decoction is a Traditional Chinese Medicine (TCM) herbal formula currently under clinical investigation for the treatment of acute gouty arthritis. Developed and studied by the Binzhou Hospital of Traditional Chinese Medicine, the decoction is typically composed of multiple botanical ingredients intended to clear heat, resolve dampness, and alleviate pain. Its therapeutic effects are characterized by the reduction of inflammatory biomarkers and the lowering of serum uric acid levels. Network pharmacology studies suggest that Wushen Decoction may act by modulating multi-target pathways involved in the inflammatory response and urate metabolism, providing a potential alternative or adjunct to standard treatments like colchicine.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Wushen Decoction.